This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Qatar University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Dana H Elkhalifa: Innovator in Chemotherapeutic Compounds
Introduction
Dana H Elkhalifa is a prominent inventor based in Doha, Qatar. She has made significant contributions to the field of cancer treatment, particularly focusing on triple negative breast cancer. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Dana's latest patents include a chalcone-based chemotherapeutic compound specifically designed for the treatment of triple negative breast cancer. These patents detail compounds, compositions, and methods that are useful in combating this aggressive form of cancer. The compounds provided in her patents are formulated to be effective in treating patients in need, showcasing her commitment to advancing medical science.
Career Highlights
Dana H Elkhalifa is affiliated with Qatar University, where she continues her research and development in the field of oncology. Her academic and professional journey reflects her dedication to improving cancer treatment options through innovative research.
Collaborations
Dana has collaborated with notable colleagues such as Ashraf Khalil and Ala-Eddin Al Moustafa. These partnerships enhance her research efforts and contribute to the advancement of her projects.
Conclusion
Dana H Elkhalifa stands out as a key figure in the development of new cancer therapies. Her innovative work and dedication to research are making a significant impact in the fight against breast cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile